These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8112521)

  • 1. Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide.
    Murty VL; Piotrowski J; Czajkowski A; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1463-6. PubMed ID: 8112521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.
    Murty VL; Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 May; 26(6):1091-9. PubMed ID: 1632804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.
    Slomiany BL; Murty VL; Piotrowski J; Grabska M; Slomiany A
    Am J Gastroenterol; 1992 Sep; 87(9):1132-7. PubMed ID: 1381553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide: effect of sulglycotide.
    Piotrowski J; Majka J; Murty VL; Czajkowski A; Slomiany A; Slomiany BL
    Gen Pharmacol; 1994 Sep; 25(5):969-76. PubMed ID: 7835646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.
    Czajkowski A; Piotrowski J; Yotsumoto F; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Apr; 29(5):965-71. PubMed ID: 8508147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroprotective agents in mucosal defense against Helicobacter pylori.
    Slomiany BL; Murty VL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosulfatase activity of Helicobacter pylori toward gastric mucin.
    Slomiany BL; Murty VL; Piotrowski J; Liau YH; Sundaram P; Slomiany A
    Biochem Biophys Res Commun; 1992 Mar; 183(2):506-13. PubMed ID: 1372502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Helicobacter pylori urease activity by sucralfate and sulglycotide.
    Slomiany BL; Piotrowski J; Slomiany A
    Biochem Mol Biol Int; 1997 Jun; 42(1):155-61. PubMed ID: 9192095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1467-72. PubMed ID: 8112522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Helicobacter pylori protease activity towards growth factors by sulglycotide.
    Piotrowski J; Slomiany A; Slomiany BL
    J Physiol Pharmacol; 1997 Sep; 48(3):345-51. PubMed ID: 9376617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.
    Piotrowski J; Skrodzka D; Slomiany A; Slomiany BL
    Gen Pharmacol; 1997 May; 28(5):705-8. PubMed ID: 9184806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide.
    Slomiany BL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1999 Feb; 32(2):251-7. PubMed ID: 10188628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Sulglycotide on the Adhesion and the Inflammation of
    Yang JY; Kim P; Jeong SH; Lee SW; Myung YS; Baeg MK; Kim JB
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32340212
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Lopez RA; Liau YH; Slomiany A
    Gen Pharmacol; 1993 May; 24(3):611-7. PubMed ID: 8365641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of sulglycotide.
    Piotrowski J; Murty VL; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1995 Mar; 35(3):467-72. PubMed ID: 7773183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori lipopolysaccharide effect on the synthesis and secretion of gastric sulfomucin.
    Liau YH; Lopez RA; Slomiany A; Slomiany BL
    Biochem Biophys Res Commun; 1992 May; 184(3):1411-7. PubMed ID: 1590801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitecapone effect on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Liau YH; Lopez RA; Slomiany A
    Gen Pharmacol; 1993 Jan; 24(1):69-73. PubMed ID: 8387047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.